ReviewPharmaceutics2023

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review.

Ludivine Boudieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.